INDIGO has developed a new assay for the Estrogen-related Receptor Beta. ERRβ is considered an orphan receptor because no natural ligand has been found that binds to ERRβ. A growing number of studies also suggest that ERRβ plays a role in tumor suppression for certain types of cancer. Our new ERR Beta assay is for sale as a commercial cell-based luciferase reporter assay for the first time.
Our ERR Beta Assay
Our Cell-based Reporter Assays are all-inclusive assay systems that feature engineered receptor-specific reporter cells prepared using our unique CryoMite™ process. INDIGO’s assay kits are engineered to provide optimal assay sensitivity and dynamic range when quantifying receptor activity. Assays are available as all-inclusive kits and as contract screening services. Get the data you need from the company with the world’s largest portfolio of nuclear receptor reporter assays.
Explore Assays
INDIGO’s effects-based bioassay solutions compliment traditional analytical chemistry approaches for the examination of water quality and can help protect human and environmental health.
Learn More
Request a quote for nuclear receptor assay panels, kits or services, or in vitro toxicology solutions
Request Quote
Scientific studies, scholarly articles, and patent information on Nuclear Receptors and Nuclear Receptor research.
Publications